Sign Up Today and Learn More About InSightec Stock
Invest in or calculate the value of your shares in InSightec or other pre-IPO companies through EquityZen's platform.

InSightec Stock (INSG)
InSightec develops and manufactures MR-guided Focused Ultrasound technology devices for image-guided acoustic surgery.
About InSightec Stock
Founded
1999
Headquarters
Dallas, TX, US
Total Funding
442M
Industries
Software, Artificial Intelligence, Data and Analytics
InSightec is the pioneer and global leader in MR guided focused ultrasound technology for image guided acoustic surgery. ExAblate® 2000 system was the first system to use the MR guided focused ultrasound technology. The ExAblate system received CE mark in 2002 and the Food and Drug Administration (FDA) approval in 2004 for the treatment of symptomatic uterine fibroids. ExAblate received the European CE Mark for pain palliation of bone metastases in June 2007 and for adenomyosis in June 2010. This device has won numerous innovation awards and has been used to treat thousands of patients around the world.
InSightec Press Mentions
Stay in the know about the latest news on InSightec
Ultrasound autofocusing using reflections
patents • Feb 07, 2025
Control of ultrasound procedures by monitoring microbubble response
patents • Feb 07, 2025
Targeted therapeutic tissue death by induced vascular disruption
patents • Feb 07, 2025
Reflection Autofocusing
patents • Feb 07, 2025
China Leads Asia’s Venture Downturn — But Other Countries Didn’t Help
news • Jan 27, 2025
Investors in InSightec
Discover investors in InSightec stock and explore their portfolio companies
InSightec Management
Leadership team at InSightec
CFO
Roni Karie
CEO & Chairman
Maurice Ferre, M.D.

Join now and verify your accreditation status to gain access to:
- InSightec Current Valuation
- InSightec Stock Price
- InSightec Management
- Available deals in InSightec and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- InSightec Cap Table and Funding History by Share Class and Liquidity Preferences
- InSightec Revenue and Financials
- InSightec Highlights
- InSightec Business Model
- InSightec Risk Factors
- InSightec Research Report from SACRA Research
Trading InSightec Stock
How to invest in InSightec stock?
Accredited investors can buy pre-IPO stock in companies like InSightec through EquityZen funds. These investments are made available by existing InSightec shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell InSightec stock?
Shareholders can sell their InSightec stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."